Whitehawk Therapeutics Inc
Price Action
Technical Summary
STAGE 2 UPTRENDWhitehawk Therapeutics Inc is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 88), indicating clear outperformance against the broad market. Earnings growth of 49% provides fundamental context to the price action. Investors should exercise caution due to high volatility (78% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $4.24 | +3.95% | ABOVE |
| 50 SMA | $4.27 | +3.32% | ABOVE |
| 100 SMA | $3.84 | +14.73% | ABOVE |
| 150 SMA | $3.41 | +29.32% | ABOVE |
| 200 SMA | $3.09 | +42.67% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is WHWK in an uptrend right now?
WHWK has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, WHWK is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is WHWK overbought or oversold?
WHWK's RSI (14) is 47. The stock is in neutral territory, neither overbought nor oversold.
Is WHWK outperforming the market?
WHWK has a Relative Strength (RS) Rating of 88 out of 99. Yes, WHWK is a market leader, outperforming 88% of all stocks over the past 12 months.
Where is WHWK in its 52-week range?
WHWK is trading at $4.41, which is 80% of its 52-week high ($5.50) and 72% above its 52-week low ($1.57).
How volatile is WHWK?
WHWK has a Beta of 1.65 and 52-week volatility of 78%. It's more volatile than the S&P 500 - expect bigger swings.